4.99
price up icon1.84%   0.09
pre-market  Pre-mercato:  4.81   -0.18   -3.61%
loading

Titan Pharmaceuticals Inc De Azioni (TTNP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
23.03%
0.657
0.534 0.666 0.754 2.074
Operating Income/Loss
23.03%
-0.657
-0.534 -0.666 -0.754 -2.074
Nonoperating Income/Loss
10.34%
-0.032
-0.029 -0.124 -0.009 -0.019
Income/Loss From Continuing Operations Before Tax
22.38%
-0.689
-0.563 -0.789 -0.763 -2.093
Income/Loss From Continuing Operations After Tax
22.38%
-0.689
-0.563 -0.79 -0.763 -2.093
Net Income/Loss
22.38%
-0.689
-0.563 -0.79 -0.763 -2.093
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.52%
1.065
0.914 0.005 0.914 0.914
Diluted Average Shares
16.52%
1.065
0.914 0.005 0.914 0.914
Basic Earnings Per Share
4.84%
-0.65
-0.62 -0.85 -0.83 -2.29
Diluted Earnings Per Share
4.84%
-0.65
-0.62 -0.85 -0.83 -2.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Capitalizzazione:     |  Volume (24 ore):